Jefferies on Inovio Pharmaceuticals (INO): 'Our near-term focus is on Type B outcome expected in ~50 days + ~30 days meeting minutes'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Hold rating and $1.80 price target on Inovio Pharmaceuticals (NASDAQ: INO).The analyst comments "Bottom ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
